Cargando…

Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes

Voltage-gated Ca(2+) channels (Ca(v)) are essential for pancreatic beta cell function as they mediate Ca(2+) influx, which leads to insulin exocytosis. The β3 subunit of Ca(v) (Ca(v)β(3)) has been suggested to regulate cytosolic Ca(2+) ([Ca(2+)](i)) oscillation frequency and insulin secretion under...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kayoung, Kim, Jaeyoon, Köhler, Martin, Yu, Jia, Shi, Yue, Yang, Shao-Nian, Ryu, Sung Ho, Berggren, Per-Olof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083041/
https://www.ncbi.nlm.nih.gov/pubmed/30044988
http://dx.doi.org/10.1016/j.celrep.2018.06.086
_version_ 1783345901829357568
author Lee, Kayoung
Kim, Jaeyoon
Köhler, Martin
Yu, Jia
Shi, Yue
Yang, Shao-Nian
Ryu, Sung Ho
Berggren, Per-Olof
author_facet Lee, Kayoung
Kim, Jaeyoon
Köhler, Martin
Yu, Jia
Shi, Yue
Yang, Shao-Nian
Ryu, Sung Ho
Berggren, Per-Olof
author_sort Lee, Kayoung
collection PubMed
description Voltage-gated Ca(2+) channels (Ca(v)) are essential for pancreatic beta cell function as they mediate Ca(2+) influx, which leads to insulin exocytosis. The β3 subunit of Ca(v) (Ca(v)β(3)) has been suggested to regulate cytosolic Ca(2+) ([Ca(2+)](i)) oscillation frequency and insulin secretion under physiological conditions, but its role in diabetes is unclear. Here, we report that islets from diabetic mice show Ca(v)β(3) overexpression, altered [Ca(2+)](i) dynamics, and impaired insulin secretion upon glucose stimulation. Consequently, in high-fat diet (HFD)-induced diabetes, Ca(v)β(3)-deficient (Ca(v)β(3)(−/−)) mice showed improved islet function and enhanced glucose tolerance. Normalization of Ca(v)β(3) expression in ob/ob islets by an antisense oligonucleotide rescued the altered [Ca(2+)](i) dynamics and impaired insulin secretion. Importantly, transplantation of Ca(v)β(3)(−/−) islets into the anterior chamber of the eye improved glucose tolerance in HFD-fed mice. Ca(v)β(3) overexpression in human islets also impaired insulin secretion. We thus suggest that Ca(v)β(3) may serve as a druggable target for diabetes treatment.
format Online
Article
Text
id pubmed-6083041
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cell Press
record_format MEDLINE/PubMed
spelling pubmed-60830412018-08-10 Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes Lee, Kayoung Kim, Jaeyoon Köhler, Martin Yu, Jia Shi, Yue Yang, Shao-Nian Ryu, Sung Ho Berggren, Per-Olof Cell Rep Article Voltage-gated Ca(2+) channels (Ca(v)) are essential for pancreatic beta cell function as they mediate Ca(2+) influx, which leads to insulin exocytosis. The β3 subunit of Ca(v) (Ca(v)β(3)) has been suggested to regulate cytosolic Ca(2+) ([Ca(2+)](i)) oscillation frequency and insulin secretion under physiological conditions, but its role in diabetes is unclear. Here, we report that islets from diabetic mice show Ca(v)β(3) overexpression, altered [Ca(2+)](i) dynamics, and impaired insulin secretion upon glucose stimulation. Consequently, in high-fat diet (HFD)-induced diabetes, Ca(v)β(3)-deficient (Ca(v)β(3)(−/−)) mice showed improved islet function and enhanced glucose tolerance. Normalization of Ca(v)β(3) expression in ob/ob islets by an antisense oligonucleotide rescued the altered [Ca(2+)](i) dynamics and impaired insulin secretion. Importantly, transplantation of Ca(v)β(3)(−/−) islets into the anterior chamber of the eye improved glucose tolerance in HFD-fed mice. Ca(v)β(3) overexpression in human islets also impaired insulin secretion. We thus suggest that Ca(v)β(3) may serve as a druggable target for diabetes treatment. Cell Press 2018-07-24 /pmc/articles/PMC6083041/ /pubmed/30044988 http://dx.doi.org/10.1016/j.celrep.2018.06.086 Text en © 2018 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Lee, Kayoung
Kim, Jaeyoon
Köhler, Martin
Yu, Jia
Shi, Yue
Yang, Shao-Nian
Ryu, Sung Ho
Berggren, Per-Olof
Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes
title Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes
title_full Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes
title_fullStr Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes
title_full_unstemmed Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes
title_short Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes
title_sort blocking ca(2+) channel β(3) subunit reverses diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083041/
https://www.ncbi.nlm.nih.gov/pubmed/30044988
http://dx.doi.org/10.1016/j.celrep.2018.06.086
work_keys_str_mv AT leekayoung blockingca2channelb3subunitreversesdiabetes
AT kimjaeyoon blockingca2channelb3subunitreversesdiabetes
AT kohlermartin blockingca2channelb3subunitreversesdiabetes
AT yujia blockingca2channelb3subunitreversesdiabetes
AT shiyue blockingca2channelb3subunitreversesdiabetes
AT yangshaonian blockingca2channelb3subunitreversesdiabetes
AT ryusungho blockingca2channelb3subunitreversesdiabetes
AT berggrenperolof blockingca2channelb3subunitreversesdiabetes